Tag: JAMA

May 7, 2020
Remdesivir a Potential Treatment for COVID-19?

The FDA allows emergency use in response to positive trials, but more research is needed.

READ MORE
April 7, 2020
Could Convalescent Plasma Treat COVID-19?

The FDA, JAMA, and others think blood from those who recovered from COVID-19 could benefit those with the illness.

READ MORE
March 4, 2020
JAMA Compares Effectiveness of Treatment Pathways for Opioid Use Disorder

A study of 41,000 adults finds that only treatment with buprenorphine or methadone reduced risk of overdose.

READ MORE
July 2, 2019
Marijuana Laws No Longer Thought to Reduce Opioid Overdose Deaths

A new study builds upon earlier research with a larger, more up-to-date dataset, finding a reversal in trends.

READ MORE
June 7, 2019
The Growing Utilization and Costs of Anticancer Medications

Though they’re only needed for special cases in workers’ comp, anticancer medications can easily exceed $10,000 per monthly fill.

READ MORE
March 1, 2019
FDA Establishes Guidance for Brain-Computer Interface Technologies

Can special implants in the brain override paralysis? The FDA believes one day they could.

READ MORE
February 7, 2019
Troubling Trends for Benzodiazepines

Prescribing has doubled since 2003, overdose deaths quadrupled since 1996, and misuse accounts for 20% of benzodiazepine use.

READ MORE
February 1, 2019
Opioid Marketing Tied to Higher Prescribing and Overdose

A new JAMA study finds that increased county-level opioid marketing was tied to elevated overdose mortality.

READ MORE
January 7, 2019
JAMA Examines Association of Early Physical Therapy with Long-Term Opioid Use

An analysis of 90,000 private claims explores the relationship between early PT and reduced long-term opioid use in musculoskeletal pain.

READ MORE
November 4, 2018
JAMA Examines Persistent Opioid Use in Workers’ Comp Patients

A study of 9,596 claimants who filled an opioid prescription found that 30% were still taking opioids 90 days later.

READ MORE
lockenvelopephone-handsetmenucross-circle